FG
MANE

Formula Growth’s Veradermics Inc MANE Stock Holding History

Formula Growth’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Sell
13,923
-77
-0.6% -$7.21K 0.6% 60
2026
Q1 		$884K Buy
+14,000
New +$706K 0.4% 87

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Formula Growth's MANE Position: Q2 2026 in Review

Formula Growth reduced its Veradermics Inc (MANE) stake by 0.55% in Q2 2026, selling an estimated $7.21K and leaving 13,923 shares worth $1.71M. The position accounts for 0.6% of the portfolio, ranked #60.

Formula Growth first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Formula Growth held 13,923 shares of Veradermics Inc worth $1.71M as of Q2 2026.
  • Formula Growth sold 77 Veradermics Inc shares in Q2 2026, an estimated $7.21K.
  • Veradermics Inc made up 0.6% of Formula Growth's portfolio in Q2 2026, its #60 holding.
  • Formula Growth first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.